Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Guly

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Rheumatology (Oxford, England)|February 2, 2021
Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measureJoanna C Robson, Celia Almeida, Jill Dawson, et al.
Rheumatology (Oxford, England)|May 5, 2023
Validation of a patient-reported outcome measure for giant cell arteritisMwidimi Ndosi, Celia Almeida, Jill Dawson, et al.
The Lancet. Rheumatology|April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trialAthimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Rheumatology (Oxford, England)|February 2, 2021
Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measureJoanna C Robson, Celia Almeida, Jill Dawson, et al.
Rheumatology (Oxford, England)|May 5, 2023
Validation of a patient-reported outcome measure for giant cell arteritisMwidimi Ndosi, Celia Almeida, Jill Dawson, et al.
The Lancet. Rheumatology|April 14, 2020
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trialAthimalaipet V Ramanan, Andrew D Dick, Catherine Guly, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
Pageof 2